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Binding and Circular Dichroism Data on Bilirubin-Albumin in the 
Presence of Oleate and Salicylate 
The bilrdiug of eyuirnolar amormts of bilirrlbill to humall and bovine sertlm al- 
bumin in 0.1 hx phosphate buH’er. pH 7.4, in the presence and absence of various 
concentrations of oleate or salicylate was studied by the use of an rlltraccutrifugal 
technique. The resldtant dat,a showed salicylate to be a poor c*ompetitor for the 
bilirubin binding sites; in the presence of :I considerable excess of salicylate, only 
small amoullts of bilirltbin were liberated from the proteins. The dissociation of 
bilirubin from albumill by oleate was very dependent on the olcate concentration. 
No bilirubiu was liberat,ed from the prot,eins at oleatc:albumin molar ratios below 5. 
-411 the bilirubilr was liberated from the proteins nt oleat~~::~lt)l~mitl molar ratios 
above 8. 
Marked chalges ilk the absorption alltl circular dichroism spectra of the bilirlLbill- 
albumin solutions were observed on the addition of salicylate or oleatc eve’~~ lmder 
conditions in which little or IIO bilirltbin was liberated from the lm)teins. While the 
binding characteristics alld absorption spectra of the humall and bovine albumill- 
bilirubin complexes in the presence and absence of oleate or salirylate were very 
similar, t,he Cotton effects generated by the additjion of bilirllbill to the hrlman al- 
bumin were very different. from thllse ot)tained with the hoviIrr proteill. 
The binding of unconjugated bilirubin b> 
serum albumin has received considerable ut- 
tention, in large part due to its clinical sig- 
nificance (l-9). Free bilirubin cm produce 
brain stem damage (kernicterus) in the sus- 
ceptible brain of t,he newborn, possibly as t,he 
result of its action as a mitochondrial toxin 
(9-U). Such action is not observed in the 
presence of albumin-bound bilirubin (9, 12, 
13). Furthermore, it has been suggested tBhat 
the presence in plasma of certain small 
organic molecules, such as salicylate, sulfona- 
mides, or fatt,y acid, which can displace 
bilirubin from albumin (4-S, 14, lci) may 
elevate free bilirubin concentrations to 
dangerous levels in pathological states in- 
volving high plasma bilirubin concent,rn- 
tions. 
The det,erminat,ion of bilirubin-albunlin 
1 Present address : Department of Medicine, 
Roosevelt Hospital, New York, N. Y. 10019. 
binding data is difficult due to the inst,ability 
and aggregation of free bilirubin in aqueous 
solution at pllysiological pH values. The 
methods which have been wed to investigat,e 
this problem have included absorption spec- 
tropliotomet8ry (4-0, lB-IS), ultracent,ri- 
fugation (S, 17), ultrafiltration (4, T), 
equilibrium dialysis (4, IS), elect,rophorcsis 
(G, 17, ZO), gel filtration (7, 21, 22) and, 
recently, optical rotnt ory dispersion (23) and 
some contradictory data have bern rcportcd. 
The invest~igations involving salicylate (4, ci, 
1G) or fatty acid (15, 16) have most’ly relied 
on changes in absorption spect,ra as indica- 
tions of changes in bilirubin binding (al- 
t~liough some semi(lu:rrit,itativc data hnvc 
been obt,ained by use of some of ttw otllr‘r 
methods listed abovc), ad thrl efficaq- of 
these small molwules in removing bilirubin 
from albumin is uncertain. 
In the present, investigat~ion it was decided 
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to determine the extent. of bilirubin-binding 
by both human and bovine albumin in the 
presence and absence of varying salicylabe or 
oleatr coneenkations by use of an ult,ra- 
centrifugal t,echnique and to semiquanti- 
tatively corroborate t’he ultracentrifugal data 
by eiectrophoretic analyses. 
Free bilirubin is optically inactive (S), 
but large extrinsic Cotton effects in the 
region of the bilirubin absorption maximum 
have been observed on the addition of bili- 
rubin to BSA (23).” Exhrinsic Cotton effects 
of this type have given much valuable in- 
formation on the binding of various small 
chromophores by optically active macro- 
molecules (23-30) since the specka we very 
sensitive to the eI~vironrnet~t at ihe binding 
site. It thus appeared that this type of 
analysis was capable of demonst,rating subtle 
changes in the binding of bilirubin by albu- 
min aft,er the addition of salicylate or oleate 
which might not’ be detected by other 
metl~ods. Circular dichroism and absorption 
spectral analyses were t,herefore performed 
in parallel with the ultracentrifugal analyses. 
MATERIALS AND METHODS 
Fisher Certified bilirubin it-s.~o,,, = 59,OCU- 
F2,OOO in chloroform) was obt#ained from Fisher 
Scient,ific Company. Analysis of standard solu- 
tions of t,wo lots of this bilirubin gave molar 
absorbances of between 59,000 and 60,~. All other 
chemicals were reagent grade. Bovine plasma 
Fraction V (Lot No. C34301) was obtained from 
Armour Pharmaceutical Company, and a re- 
worked human plasma Fraction V was obt,ained 
from theMichigan Department of Health, Division 
of Laboratories, Lansing, Mich., through the 
courtesy of Dr. James Sgouris. The Fraction \’ 
preparations were obtained in preference to crys- 
talline albumin preparat,ions since the latter 
generafly contain deeanol which might alter t,he 
binding characteristics of the albumin and which 
is dificult to remove from the protein. 
H~lrnan and bovine albumin preparations were 
obtained from the Fraction y  powders by exhaus- 
tive dialysis of 87, solutions against dist,illed water 
followed by passage of the dialyzed solutions 
through mixed-bed deionizing columns (31) t,o 
remove most of the globulins present in the Frac- 
tion \‘ preparations. The deionized solutions were 
-- 
2 Abbreviations used are: HSA, human serum 
albumin; BSA, bovine serum albumin; CD, circu- 
lar dichroism; ORD, optical rotastory dispersion. 
~~illipore-filtered, freeze-dried, and the dry pow- 
ders stored at 2’. Electrophoretic analysis of the 
albumins gave only one band on Sepraphore III 
strips. Ultracentrifugal analysis showed bot,h 
human and bovine preparations to contain about 
5% dimer. The fatty acid content of the BSA was 
0.4 moles/mole while that of the HSA was 1.1 
moles/mole as determined by the method of Dole 
(32). 
The protein concentration of the stock albumin 
solutions was determined by absorbance measure- 
ments using the following previously determined 
absorbances (E &. 279 mr): HSA, 5.34; BSA, 6.67. 
The molecular weight of albumin was taken as 
66,ooo. 
Protein determinations on the bilirubin-albu- 
min solutions were performed using the biruet 
reagent (33). Salicylate, present in many of the 
solutions, interfered wit,h this technique and was 
removed by precipitating and twice rewashing the 
protein with 3% trichloroacetic acid. The final 
precipitate was redissolved in 1.5 ml water, mixed 
with 4.5 ml biuret reagent, and the absorbance of 
the resultant solution measured after 20 min 
against a reagent blank at 550 mp in a Coleman 
spectrophotometer. 
Bilirubin determinations were carried out by 
the method of Jendrassik and Grof as modified by 
Gambino (34). However, since salicylate also 
reacted with the diazo reagent, it was necessary to 
increase the sodium nitrite concentration to 5.0 g/ 
100 ml and add 2 ml of this solution to the sulfanilic 
acid solution. The salicylate react,ion product had 
an absorption maximum at 450 rnp but even in high 
concentration exhibited negligible absorption 
above 580 rnp. Since the biiirubin reaction product 
was read at its absorption maximum of 600 rnp, the 
presence of even large excesses of salicylate did not 
interfere with t.he estimation of bilirubin concen- 
t,ration. For uniformity, this modification was 
adopted in all bilirubin determinations including 
t,hose on the standard solutions. 
Fatty arid-free TTSA was prepared by the 
charcoal defatting method of Chen (35). Colloidal 
charcoal remaining in t,he protein solution at the 
end of the procedure was removed by passing the 
solution down a short DEAE-Sephadex A-50 
column, 0.2 M phosphate buffer, pH 7.0 at 2”. The 
result.ing preparation contained < 0.01 moles 
fatty acid/mole IISA. 
Stock albumin solut,ions were prepared by dis- 
solving the albumin powders in 0.1 M phosphate 
buffer, pII 7.40, det,ermining the albumin concen- 
trations by absorbance measurements at 279 rnp, 
and sdjusting the volume of the albumin solutiun 
wit.h buffer such that the fmal albumin concentrit- 
tion was 68.4 p~ (0.451 g/100 ml). An equimolsr 
bilirubin solution was prepared by dissolving 4.00 
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mg bilirubin in a few drops of 0.2 1% NaOH and 
diluting to 100 ml with the pH 7.4 phosphate 
buffer. In all experiments except those in which 
bilirubin concentration was a variable, equal 
volumes of the albumin and bilirubin solutions 
were mixed to give a 34.2 p~ solution of 1:l bili- 
rubin-albumin. 911 bilirubin-containing solutions 
were prot,ected from light by wrapping the con- 
tainers in aluminum foil. After initial mixing, the 
absorbance of the bilirubin-albumin solutions in 
the region of the bilirubirl-albumin absorption 
maximum increased with time until a stable 
plateall value was reached about 4 hr after mixing. 
On further st,anding, a very slow decrease in the 
magnitude of the absorption occurred. This 
greater st,ability of the albumin-bound bilirubin 
permitted the use of the lengt,hy ult,racentrifuga- 
tion procedure to determine albunlin-bound bili- 
rubin concentrations without seriolls error due to 
oxidation of the bilirubin. The absorpt,ion and Cl) 
spectra of the I:1 bilirubin-albumin solutions 
after ultracentrifugation were not, significantly 
different, from those obtained -1 hr after mixing of 
the constituent solutions. All absorption and CD 
spectra recorded in this paper were obt,ained 4-12 
hr after mixing t.he bilirubin and albumin solu- 
tions. To minimize variables, no ascorbic acid was 
added to the solutions to stabilize bilirubin against 
oxidation. 
Various dilutions of a standard ethanolic solu- 
tion of oleic acid were added to the 1:l bilirubin- 
albumin solutions (0.2 ml oleic acid solution: 10 ml 
bilirubin-albumin solution) to give the desired 
oleate:albumin molar ratio. A standard stock 
salicylate solution was prepared in the pH 7.1 
phosphate buffer, and serial dilutions of this solu- 
tion were used to obtain the desired salicylate 
concentrations. Due to the relatively high salic- 
y1at.e concentrations which were present in some 
of the bilirubin-albumin solutions, it was neces- 
sary to add somewhat large volumes of salicylate 
to the bilirubin-albumill solutions, and the salic- 
ylate-bilirubin-albumin solutions were prepared 
by mixing 1 vol of salicplate solution with 4 vol of 
the 34.2 pM 1:l bilirubin-albumin solutions. The 
oleic acid and salicylate were added to the bili- 
rubin-albumin solutions immediately after the 
preparation of the latter, and the well-mixed sol~l- 
tions were allowed to stand in the dark for 1 hr 
before use. 
Absorption spectra were obtained using a Cary 
Model 15 recording spectrophotometer, and the 
absorbances of the albumin solutions at 279 rnr 
were measured on a Zeiss PM& II spectrophoto- 
meter. Circular dichroism measurements were 
performed on a Jasco ORD/UTT/Cl>-5 spect,ro- 
polarimeter at 25”. The optical lengths of the 
quartz cells were 4.5 and 9.0 mm. The absorballces 
of the solutions did not exceed 0.6 above 300 IW. 
The slit width was never greater than02mmabove 
300 m& wavelength and the scale setting was 0.005 
or 0.002. Circular dichroic absorption coeflicients 
(4~) were calcnlated losing the relationship 
4,t = c, - tr = 4k. a/cl, 
where 6, and tr are the absorbances of the left and 
right circularly polarized light, 4k is the experi- 
mentally measured difference in absorbance of left 
and right circularly polarized light, s the scale 
setting, c the molar concentration of bilirubin, and 
1 the optical path 1engt.h in centimeters. No correc- 
tions for refractive index dispersion were made. 
An ult,racentrifugal technique was used to 
determine the albumill-bound bilirubin concen- 
tration on the basis of whether or not the bilirubin 
sediment.ed with the albumin. The bilirktbin- 
albumin solutions were placed in 12-ml plastic 
centrifuge tubes in t,he Xo. 40 rotor of a Spinco 
Model L ultracentrifuge and centrifuged for 36 hr 
at 39,ooO rpm at 15”. At the end of this time the 
albumin and bomid bilirubin had sedimented to 
the bottom 2 ml of the centrifuge tube, whereas 
any free colloidal bilirubin had sedimented to the 
bot,tom of the tube where it packed as an orange 
pellet. The top 10 ml of the centrifuge tube COII- 
tained only traces of bilirubin or albumin and w&s 
removed by use of a tube-cutter (36). The remain- 
ing bottom 2 ml of the bilirubiii-albumin solrltjion 
was carefully removed from the bilirubiu pellet 
and analyzed for protein and bilirnbin. 
Elect,rophoretic studies were performed on 
Sepraphore III strips in a Gelman Rapid Electro- 
phoresis chamber in 0.05 M phosphate buffer, pH 
7.4, at 200 1. and a current of approximately 3 mA 
per strip for 85 min at 2”, and 20~1 of the hilirubin- 
albumin solution was applied to each strip. Bili- 
rnbin-containing bands were observed visually 
while the location of t)he albumin was determined 
after staining with amido black 10B. 
RESULTS 
Ultracentrifuyal &dies. Protein and bili- 
rubin determinat,ions were performed on the 
albumin-containing fraction of the 1: 1 
bilirubin-albumin solutjions in t,he presence 
and absence of oleate or salicylate after 
ultracentrifugation of t,he solutions. The 
amount of bilirubin which remained bound 
to the albumin in the presence of various 
concentrations of oleate is shown in E’ig. 1. 
No orange bilirubin pellet could be detected 
at, the bot,tom of the t,ubes which contained 
110, or low concentrations of, oleate. At, 
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FIG. 1. 1)issociation of bilirubin from 1:l bili- 
olr:~l~t~ concentrxtions bet wccn 4 and S 
moles Jmole bilirubin-ulbumitI I here \vas :t 
marked increase in the size of the hilirubin 
pello[3 2s t~lte 01&e eotlcentP>~t ion increased. 
The sm:l!l but positive bilirubin values which 
v,we obtained in thtl prwence of an S-fold or 
grcnt,er csce~s of oleatc were probably due to 
inaccuracies in the bilirubin :msa~- ;11 ~,hese 
low bilirubin Icvels and to the presence of 
t r:tccs of ~in~ediil~el~ted frw bilirubin in the 
ultr:lcentrifuged solutions. In all other in- 
st:uxes tluplic:~t c bilirubin :md pro1 rin det cr- 
min:U ions agreed to w4t,hin 2 7;. 
Tlw effect of salicylalc on t)he binding of 
bilirubin bv albumin in the presence and 
;~bww 0; low ole:~ c ~orlce~~tr~~t,~~~Il~ is 
sllown in Iq’igs. 2and3. Tl~eeffect of salicylat~e 
NW much less marked t 11an that of’ oleat,e, 
:mtf :I slox bu: steads 10s~ of bilirLlbiI1 was 
obwr\cb:l :\:i the ssiicylat e concentration 
inerc~:~sc:c!. The loss of USA-bound biiirubin 
(Fig. 3) was somewhat great.er than that, of 
HSA-bound bi!irubin (Fig. a), especially at> 
the louver ;I;slicylate concent rations. The 
adtlit,ion of low ~once~~t,r~t.iotls of &ate to 
the s:tlicylat,e-biiirubin-albumin solut,ions 
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MOLES SALICYLATE/MOLE I I BILIRUBIN - HSA 
FIG. 2. I)issocintion of bilirubin from I:1 hiti- 
rubin-HSA by sttlicylate in the presence :uld 
absence of low concentrations of oleate. Iniiial 
HSA (~nl~~e~i~r~~ti~)il = 27.4 ,a~. 0, no o!eatc; +, 1 
mole oleate; X, 2 moles oleate; El, 3 moles ol~at c; 













/  , ; I  
0 114 228 " 456 9ti 
MOLES SALICYLATE/MOLE I I BILIRUEIN - BSA 
FIG. 3. I~issoektion of bilirubin from 1:l 
~ili~tl~~il~--~S~~ by salicylate in the presence and 
absence of low ooncentr:ttions of oleate. Init id 
ES.4 concent,wt,ion = 27.4 PM. e, uo oleate; +, 1 
mole rdeak; X, 2 moles olexte/mole l~~lirllbi~~-- 
BYA. 
bindil~~ ~lt~~o~~~l~ the dat.lz obtained wit 11 
HSA did show some increase in the loss of 
bilirubin following the addition of oleate. 
~l~~~~~~~,~r~~~~ stu&Ies. Protein and bili- 
rubin determinations were not, performed on 
the electrophoresed bilirubin-albumin solu- 
t iota. The bilirubin and protein bands were 
esGm:~ted visually before and after staining 
with amide black 1OB. I’ree bilirubin did 
ttot migrate in the electric field :tt pH 7.4 
:tnd could be observed as a yellon- band at 
I IIC origin. I~ound bilirubin migrat cd \vit h tlrr 
albumin t,o t,he anode :IS a yello~v band \vhich 
bwumc blue after staining n-it 11 the amid0 
black. The 1: 1 bilirubin-:rlbumin sohttiotts 
and t hosc~ \vlticlt contained less than :I .5 :\I 
~wxss of olent e sho\ved no yellow band at 
tl~e origin and :t sl rang yellow bilirubin- 
:tlbutnin band. As the oleutc concent r:ttion 
\V:LS incrensed above 5 moles/mole bilirubinP 
:~lbumin, bilirubin could be seen at tire origin 
in increasing amounts while the yellow color 
associated \vit It the albumin brand decreased 
\\-ith itictwrsing oleal e concentration. When 
:ttt %!I-fold excess of oleate n-as present, no 
JY~IIOW color could be discerned at the posi- 
t ion of the albumin band. ~~%~I~ elcctro- 
pltoresis was performed on solui ion:: which 
contained salic\-lut e, :t gradual increase in 
(lte intensity (;f t ltr bilirubin band :rt the 
origin w:w observed as t,lte sa,licyl:tte con- 
mbnl rat ion was increnscd. 
Since it has been shown ihat the optical 
itroper’t ies of bilirttbi~~~~lbltrnir~ solutions 
c:tn depend on the order of mking tlte COII- 
stit uents, on the nature and concentration 
of’ the added electrolyte, and on the pH (23)) 
it should be reemphasized here tlt:l1 all 111~ 
data reported in this section of the paper 
\wre obtained by mixing 0.1 II, pH 7.4. 
pltosphut e buffer solutions of the bilirubin 
and :dbumin, adding oleatc or salicylat P 
\vhett required, and allo\ving the soltttions to 
st :md for -1-12 Itr in the dark before use. The 
p1-I of the final solutions was 7.30 * 0.05. A 
i’r\v absorption and CD spectra were obt:Cncd 
on solutions in which most of the pliosph:~le 
had been repl:~ced by SaC’l. Tl~c spectra 
\\we indistingruishablr from tltose obtairtcd 
t\-ith phosphate alone. 
Ak~rp~Gvz spectra. The spectra of bili- 
rrtbirlPHSA and bilirubirlPRSA solutions in 
the presence of 0..5-4.0 moles bilirubitl/molr 
albumin showed a steady increase in the 
intensity of the absorbance at 450P3B0 rnp 
:ts the bilirubin concentration increased. This 
red shift. in tlte \v:~velength of the bilirubin 
absorption maximum (free bilirubin has an 
absorption maximum at 33;5-440 mk) ~vas 
most pronounced at the lower bilirubin con- 
cr~titr~~tiottr L 4 and w:ts :tccomp:mied by :t 
distinct shoulder to 1 he absorption cur\w in 
the 420-~430 mp wgioti of 111~ spectra. 
The :tbsorbattcr coefficient of the 1 : 1 bili- 
rubiwHS,I (c,,,\~, 15F ,,J uxs 4.5 =t 2, in good 
agrrement~ witli the v:~lue of 46 (MO mp) 
reported b!. Odcll (4), wltile (Itat of tltc 
bilirubin -HS:\ (C ,,,, I, ,e,) ,,J uxs 54 f 2. Tllis 
latter v:tlttr is somewhnt lower than Idie 
wlue of K<.:? reported b!- Hlaucr and Thing 
(23) for bilirubirtPHSh at pH ‘i..;. l’urtltcr- 
more, these :tut Itors observed 111~ wave- 
length of the absorption maximum to be 
1714’72 Ill/L, a \v:tveletlg~ h cottsidcr:tbl~ 
longer than the 4(iO-mF :tbsorp~ion maximum 
observed in tlte present invcstig:ltiotw. 
Micylute, iti concentrations up to lOOO- 
fold excess, \vw added to 1 : 1 bilirubkllSh 
solutions. :Is tltc s:ilic!-late concctttratioti IV:IS 
increased, there w:w :I progressive dccrc:wc 
in the inl ensit y of the :~bsorption and :L bhte 
shift in the n-nwlength of tlte :tbsorpt ion 
maximum t o\vards that, of free bilirubin. III 
tlte prcsrnce of 100.fold excess of salicylut r! 
the absorbance coefficient, at the nbsorpt,ion 
m:iximum (450 trip) w:Ls 46 rnlt-1 ~n--~. The 
spectra obt :rincd ivith bilirubinvHSA showed 
similar but less marktrd changes as tlte wli- 
cylai c concentration increased and \vcre in 
general agrcemetil with tlic sped ra rcportcd 
by Ode11 (4, l(i) rind W:~tsorl (6). 
Adore complex results \verc obtained uhrn 
olratr rat her t halt s:tlic>.l:l1 t’ n-as added to 
1 Itv bilirubittP:rlbumin solutions (P‘igs. 3 and 
5). 121 low olt’:Ltc coticrtitr:~fiotts (up to :<&I 
molts olrat tJ’/imol(’ bilirttbin albumin) Iltere 
nxs :m inctwse in the intensity of the :~bsorp- 
f ion wit II :I sligjrt red sltift in t Ite absorption 
maximum. .Is t Itch olrat e concetttration \v:ts 
incrwscd above t Ittw wluc~:, this pwk 
decrwscd in intcnsit y and the spectjra ex- 
ltibitrd :t broad pr:tk ivitlt :L maximum at, 450 
:ttid :I pt~onouttced shoulder :tt 490 mp. These 
spcct r:t (‘7-S moles oleate~imole bilirubiw- 
HSA and fi moles olt~ate,!tnole bilirubin- 
HSA) were slrikittgly similar to those ob- 
srrwd by ;\Iust afn and .I<ittg (I:{) and on 
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400 450 500 550 
X(mp) 
FIG. 4. Absorption spectra of 1:l bilirubin- 
HSA (33.5 PM) in the presence of 0, 1, 2,3,4,5, 6, 7, 
and 10 moles oleate/mole bilirubin-HSA. Optical 
path length = 4.5 mm. Left, ordinate, absorbance 
of solutions and right ordinate, millimolar absorb- 
ance coefficient (rnM-l cm-l). 
the addition of mitochondria or mitochon- 
drial lipid to bilirubin. 
Spectral measurements were also con- 
ducted on some 1: 1 bilirubin-albumin solu- 
tions to which both oleate and salicylate had 
been added. At low oleate concentrations 
(below 4 moles oleat’e/mole bilirubin-albu- 
min) the spectra were composites of those 
obtained with oleate or salicylate alone. At 
higher oleate concentrations the effect of the 
oleate almost’ completely overwhelmed that 
of the salicylate except’ at very high salkylate 
concentrations (above 500 moles salicylate/ 
mole bilirubin-albumin). The effect of sali- 
cylate on the oleate-bilirubin-HSA solu- 
tions was somewhat less pronounced than 
that observed with the bovine protein. 
Circular dichroism. Free bilirubin exhibits 
no circular dichroism in either aqueous3 or 
chloroform solution. At the concentrations 
studied, the albumin solutions displayed no 
circular dichroism at wavelengths above 300 
8 Unlike the observations of Blauer and King 
(23) at low salt concentrations, no optical activity 
was detect.ed in the free bilirubin solutions which 
cont,ained 0.1 M phosphate, pH 7.4. 
400 450 500 -; 
X(mp) 
J 25 
FIG. 5. Absorption spectra of 1:l hilirubin- 
BSA (33.5~~) in the presence of 0, 1, 2,3,4,5, 6,7, 
and 8 moles oleate/mole bilirubin-BSA. Optical 
path length = 4.5 mm. Left ordinate, absorbance 
of solutions and right ordinate, millimolar absorh- 






FIG. 6. CD spectra of HSA (11.4 PM) in the 
presence of 0.25, 0.5, 0.75, 1.0, 2.0, 3.0, and 4.0 
moles bilirubin/mole HSA. Optical path length 
= 4.5 mm, scale setting = 0.002. Left ordinate, 
CD absorption of solutions and right ordinate, 
molar CD absorption coefficient (M-l cm-l). 
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400 450 500 
X(rn/J 
FIG. 7. CD spectra of BSA (11.4 PM) in the 
presence of 0.25, 0.5, 0.75, 1.0, 2.0, 3.0, and 4.0 
moles hilirubin/mole BSA. Optical path length 
= 4.5 mm, scale setting = 0.002. Left ordinate, 
Cl) absorption of solutions and right ordinate, 
molar CD absorption coefficient (M-I cm-l). 
rnp and showed only a shoulder between 250 
and 300 rnp before the st’rong absorption at 
lower wavelengths. The CD spectra of 
bilirubin-HSA and bilirubin-BSA in the 
presence of various amounts of bilirubin are 
shown in Figs. 6 and 7. Both proteins gave 
biphasic spectra in the region bekeen 300 
and 500 mp. As the bilirubin concentration 
increased, the spectra obt,ained with the 
HSA showed a steady increase in the in- 
tensity of a positive Cotton effect at about, 
460 rnp and a negative Cot,ton effect at 
about, 410 rnp and had a crossover point at 
431 rnp. The spectra obtained with BSA 
were more complex. At bilirubin concentra- 
tions up to 1 mole/mole BSA there was a 
steady increase in the intensity of t,wo CD 
bands at 472 and 416 rnp as the bilirubin 
concentration increased. Above equimolar 
bilirbuin concentrations t,he two bands de- 
creased in intensity and eventually changed 
sign such bhat in the presence of a 4 AI excess 
of bilirubin t,he spectra showed a small 
positive band at 473 rnp and a somewhat 
stronger negative band at 392 rnp. 
Replicate measurements on 34.2 ~31 1: 1 
bilirubin-HSA solutions gave a circular 
dichroic absorption coefficient (AQ, 456,,J of 
37 Z!Z 1. The coefficient obtained with the 
BSA solutions (AcAr, J,~~,,,) was 72 f 1, 
approximately twice that of the human pro- 
tein. Blauer and King (23) have reported 
the wavelength of the inflection point of the 
ORD Cotton effect to be 472 rnp, a wave- 
length identical to that observed for the 
minimum of the major bilirubin-BSA CD 
band. This wavelength identity is in sharp 
contrast to the comparable absorption 
spectra maxima which were at 471-472 
(Blauer and King) and 460 rnp (this paper). 
These differing results could be due to 
differing ionic strength (Blauer and King’s 
studies were conducted in approximately 1 
ml1 NaCl) or to the use of differing protein 
preparations. In this regard, one experiment 
was performed in which crystalline BSA 
(Armour Pharmaceutical Co., Lot No. 
E71.503) which contained decanol and 0.66 
moles fatty acid/mole BSA was substituted 
for the BSA prepared from Fraction V. The 
CD spectra of this 1: 1 bilirubkBSA prep- 
aration showed a similar CD band at 472 
rnp but no CD band at 416 mp. 
The CD spectra were obtained after the 
addition of salicylate to the 1: 1 bilirubk 
albumin solutions. Progressive addition of 
sulicylate to the 1: 1 bilirubin-HSA resulted 
in a progressive decrease in the intensity of 
both CD bands although the trough at 403 
rnp n-as more affected by low salicylate con- 
centrations than n-as the peak at 456 mp. The 
changes produced in the bilirubin-BSA 
spectra were greater and more complex 
(Fig. S). Relatively low concentrations of 
salicylate (11 moles/mole bilirubin-BSA) 
reduced the magnitude of the trough at 472 
rnk to about half of its original value and 
almost complet8ely extinguished the smaller 
peak at 416 mp. 
The addition of oleate to 1: 1 bilirubin- 
HSA (Fig. 9) produced a steady, marked 
decrease in the magnitude of the peak at 
456 rnk with increasing oleate concentration. 
The trough at 405 rnp, however, did not 
decrease in intensity until 3 moles oleate,/ 
mole bilirubiIIPHSA had been added to t,he 
solution. When a ii- or G-fold excess of oleate 
was present, the spectra changed in char- 
acter and new CD bands of low inter&J 
were observed. Spectra obtained after the 
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FIG. 8. Cl) spectra of 1:l bilirubin-BSA (27.4 
PM) in t.he presence of 0, 11, 23, 114, and 456 moles 
salicylnte/mole bilirubkBSA. Optical pat,h 
length = -4.5 mm, scale set,ting = 0.002. Left 
ordinate, Cl> absorption of solut,ions and right, 
ordinate, molar Cl) absorption coefficient (w-1 
cm-l). 
addition of S moles oleatejmole bilirubirl- 
HSA exhibited essentially no circular dichro- 
ism above 300 rnk. 1 
The complex spectra obtain& on the 
addition of oleate to 1: 1 bilirubin-BSA are 
shown in Fig. 10. A complete loss of t#lie 
peak a,t 416 rnp and a considerable decrease 
in the magnitude of the trough at 472 mM 
were observed on the addition of 1 mole 
oleate/mole bilirubinPHSA. E’urther in- 
creases in oleate concentration further de- 
creased the trough at 47% rnp and :L new 
trough at 42.5 mp appeared. As the &ate 
concentration was increased above 4 moles/ 
mole bilirubiwBSA, the CD bands progres- 
sively decreased in intensity until in the 
presence of S or more moles oleatcimole 
bilirubiwBSA the Cotbon effect, had been 
completely abolished. In vie\v of the great 
differences in the CD spectra of the HSA 
and BSA complexes it is interesting to note 
that the spectra of botll proteins displayed 
a small positive band at about 500 mp after 
the addition of a G-fold excess of oleate. 
Investigation of the CD spectra of bili- 
rubin-albumin solutions containing both 
oleate and salicylate produced results similar 
to those observed with the absorption 
spectra. The less pronounced effect of sali- 
cylate on the absorption and CD spectra of 
FIG. 9. Cl) spect r:t of 1: 1 bilirubinPIISA (YY.5 
PM) in the presence of 0, 1, 2, 3, 4, 5, (i, and 8 molvs 
oleatelmole bilirnbin-IfSA. Optical path length 
= 4.5 mm, scale setting = 0.002. Left ordinate, Cl) 
absorption of solrltiolls and right ordinate, mo1;11 




300 400 500 
A(mp) 
FIG. 10. Cl) spectra of 1:l bilirubirl-BSA 
(33.5 PLY) in the presence of 0, 1, 2, 3, 4, 5, 6, and !) 
moles oleate/mole I)ilirrlbinPBSA. Optical pal h 
length = a.5 mm, scale setting = 0.002. I,eft 
ordinate, Cl) absorption of solutions and right 
ordinate, molar Cl) absorption coefficient (XI-’ 
cm-l). 
the bilirub&HSA complex, especially at the 
lower salicylate concentrations, paralleled 
the binding data in which the loss of bili- 
rubin from the bilirubirl-HSA was not as 
great as that observed with the bovioc* 
protein. 
Hrmxtin and E:van’s blurb, both of b\-hicll 
arc tightly bound by albumin (37), were 
added to BSA solutions in equimolnr 
amounts in pH 7.4 0.1 11 phosphate buffer. 
So extrinsic C&ton effects were observed 
with either solution nor did the addition of 
equimolar amounts of thew compounds to 
1: 1 bilirubin-BSA alt,er the CD spectrum 
of that complex. Rosenfeld and Snrgenor 
(37) huvc reported that’ the add&ion of 
bilirubin did not affect the binding of 
hematin bv albumin and have suggest’ed 
that the biiirubin and hematin binding sites 
are different and independent of one another, 
a situation which wmld be in accord with 
the CD data. 
Since the HSA preparation contained over 
1 mole fatty acid/mole HSA, it was decided 
to defat the protein and examine the CD 
spectra of the defatted BSA after the addi- 
tion of equimolar amounts of bilirubin. The 
spectra obtained with the 1: 1 bilirubin- 
defatted HSA solutions in t#he presence and 
absence of low oleate concentrations were 
very similar to those obtained with t,he unde- 
fnt,ted protein although some enhancement 
in the intensity of the CD band at 4% rnp 
was observed in the absence of oleate. 
DISCUSSION 
The instability, aggregation, and insolu- 
bility of free bilirubin in aqueous solution at 
physiological pH values presents serious 
technical problems in investigations involv- 
ing this compound. While various and some- 
times contradictory values have been re- 
ported for the solubilit? of bilirubin, the 
most complete investigation of this problem 
is that of Burnstine and Schmid (3). They 
found the solubility of bilirubin in 0.1 M 
phosphate, pH 7.4, to be about. 7 mg,‘lOO ml. 
However, interpolation of their data to pH 
7.4 ionic strength 0.1 phosphate buffer gives 
a bilirubin solubility t#hat is about 30 times 
greater than the value of 0.1 mg,/lOO ml r+ 
ported by Lwtin (IS) at the same pH :md 
ionic strength. Equilibrium dialysis (4) and 
ultrafiltration (4, 7) data involvirlg bilirubin 
concentrations of I mgjlO0 ml or greater 
have been reported, but we were unable t,o 
even approach equilibrium bilirubin con- 
centrations on dialysis in cellulose dialysis 
tubing of 34.2 ~L.\I (2 mg/lOO ml) bilirubin 
solutions in 0.1 11 phosphate, pH 7.4. 
l~urthermore, ultrafiltration of the bilirubin 
solut’ion through :L Diaflo 1’WlO membranr 
(exclusion mol \vt approx. 10,000) resulted 
in :f filtrate \vhicll cont:tinrcl only traces 01 
bilirubin. 
Of the other metllods availablt~ for deter- 
mining the extent of bilirubin binding b> 
albumin [gel filt8ration (T, 31, 22)> electro- 
plioredis ((i, 17, 20) 1 tlw peroxidase metlwd 
of Jacobsen (SO), :urd ultr:~centrifIlgatiorl 
(S, 17)] the last named WE deemed most, 
suitnblc for large numbers of samples. It, also 
had t,he advantage tllat it did not subject tilt: 
solutions to liglit or t,o large volumes 0i 
oxygen-contuiliitig sol\-etit,s or solid matricw 
which could promote oxitlat’ion of’ tlw bili- 
rubin. There was somt: concern about t811c 
long period of t#ime required for the &la- 
crntrifugat,ion, but preliminary investiga- 
t,iona on the absorpt8ion and CD spectra of 
t’he 1: 1 bilirubin-:llbumirl sohltions befow 
and after centrifugatioll showed the complcs 
to be stable under t8hrse conditions. ,1 furthw 
problem could be encountered in the bili- 
rubin-albumin solutions which contwinc(1 
oleate or sulicylate and free bilirubin. Since 
all but traces (< a(,,) of the free bilirubin 
sedimented t#o t,llc bottom of the cwtrifugC~ 
tube where it packed as a pellet, true ttquilib- 
rinm between albumin-bound bilirltbin antI 
free bilirubin was not achieved. This col~ld 
introduce an error into tllc correlat!ion of 
spectral and ultracentrifugal d&r if the 
presence of the oleate or salicylntc reduwtl 
the association constant of the bilirubin fog 
t’he nlbumin to a sufficiently low value 
resulting in liberation of bound bilirubin 
during centrifugation. However, the loss of 
t’lie extrinsic Cotton effects in the CD spectr:L 
at the same olcnte coticcntrntions as tlwsc 
wllich result~etl in loss of bilirubin binding as 
detwmined by the ultracentrfuge t~xpwi- 
mcnt8s (%Y mole3 olcnt,e,/mole bilirubitl- 
albumin) would indicate that the binding 
data represent reasonabl!- :accu&e estimnt,cs 
of t,he extent of bilirubin binding at the 
major bilirubin binding sites on the albumin. 
Furthermore the elcctroplwrctic data pro- 
vide some corroborat8ive widence for tlre 
validiby of t’he ult8racentrifugal data although 
hew again bhe bilirubit-albumin was rc- 
moved from t’hc free bilirubin during electro- 
plioresis. 
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Recent data obtained by Jacobsen (39) 
have shown that the major bilirubin binding 
sites on HSA are of two classes, the first 
containing a single site at which bilirubin is 
bound with a dissociation constant of 7 X 
10dg M at pH 7.4 in 0.1 11 Tris-HCl buffer and 
the second containing two sites with corres- 
ponding constants of 2 X 1OW M. Thus in a 
1: 1 bilirubin-HSA solution, the bilirubin 
binding should occur almost entirely at the 
primary binding site, and the simplifying 
assumption can be made that the entire 
Cotton effect arises from the stereospecific 
binding of a single bilirubin molecule at a 
single asymmetric locus on the HSA mole- 
cule. 
Similar binding data are not available for 
BS,4; however, the ORD titration data of 
Blauer and King (23) have indicated the 
presence of one primary bilirubin binding 
site on BSA with an association constant of 
5.7 X lo6 111-l at pH 5. Data obtained at pH 
7.4 indicated that’ the association constant 
at, this pH was at least one order of magni- 
tude greater than that determined at pH 5. 
The existence of one primary bilirubin bind- 
ing site on BSA is also suggested by the CD 
spectra obtained in the presence of various 
bilirubin concentrations as shown in Fig. 7. 
Progressive addition of bilirubin to BSA up 
to equimolar bilirubin concentrations pro- 
duced a steady increase in the intensity of 
both Cotton effect CD bands as would be 
expected for the purely additive effect of 
saturating a single site. As the bilirubin con- 
centration was raised above the 1: 1 molar 
ratio, the CD spectra changed in character 
as if secondary binding sites producing 
different Cotton effects mere now binding 
bilirubin. Furthermore, the association con- 
stant of the BSA primary bilirubin binding 
site must be greater than lo7 a+ in pH 7.4, 
0.1 M phosphate buffer since less than 5 % of 
t#he bilirubin was not albumin-bound after 
ultracentrifugation of the 34.2 ,utir 1: 1 
bilirubin-albumin solutions. 
The molar amplitudes of the major 1: 1 
bilirubin-albumin CD bands are high. The 
hr. 472 mll of the 1: 1 bilirubin-BSA is 72, 
greater than the values reported by Schech- 
ter (30) for the covalent binding of 2,7- 
dibromo-4-hydroxy mercurifluorescein to the 
sulfhydryl group of BSA (Ae,, , 540 ,,,c = 13 
at pH 5 and 5 at pH 7) and the noncovalent 
binding of equimolar amounts of pyridoxal 
phosphate to BSA (AC,,, 335 ,np = slightly 
over 4) and is the same order of magnitude 
as those reported for the major CD bands 
of various species of cytochrome c at about 
400 rnp (40). While both 1: 1 bilirubin- 
albumin complexes are very similar in their 
behavior, the spectral data provide striking 
evidence for the nonidentity of the primary 
bilirubin binding sites on the two proteins. 
Although the magnitudes of the molar 
absorbances at the absorption maxima are 
quite similar, t,he magnitude of the major 
BSA CD absorption maximum is about 
twice that of the HSA. Furthermore although 
the wavelength of maximun absorption is 
the same for both the absorption and CD 
spectra in the case of the HSA, the major CD 
band observed with the bovine protein has 
a maximum at a wavelength 12 rnp longer 
than that observed in the absorbance 
measurements. 
Blauer and King (23) have interpreted the 
large Cotton effect which they obtained with 
bilirubin-BSA at pH 5 as being associated 
with a high degree of inherent dissymmetry 
and dipole-dipole coupling in the bound 
bilirubin molecule and have proposed that 
the bilirubin bound to BSA prossesses the 
sense of a right-handed helix. They have also 
suggested that a less dissymmetric con- 
formation with a reduced degree of dipole- 
dipole coupling between the chromophores 
of the two bilirubin halves exists at more 
alkaline pH values. Some such couplet could 
be largely responsible for the Cotton effects 
observed with the bilirubin-HSA at pH 7.4 
(41) where the symmetry of the two CD 
bands is most pronounced. The complexity 
of the bilirubin-BSA spectra would suggest 
that it is a composite of several different 
types of interaction and that any unique 
description of the configuration of bilirubin 
bound to BSA will require further informa- 
tion on the nature of the various transitions 
which contribute to the Cotton effects. While 
very little information is available on the 
bilirubin and albumin groups which are 
necessary for bilirubin-albumin association, 
two relevant facts have been published: (1) 
guanidination of the lysyl residues of HSA 
results in greatly decreased binding of bili- 
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rubin (18) and, (2) the methyl ester of 
bilirubin is bound by albumin as strongly as 
is bilirubin (42, 43). 
While no oleate or salicylnte binding 
measurements were performed on the bili- 
rubin-albumin solutions which contained 
these anions, previously reported data on 
the binding of oleate by BSA (44) at pH 7.4 
021 = 3, lcl’ = 3.96 x 10”; 7/Z = 3, Ic,’ = 
1.26 X 105; )1,3 = 63, k3/ = 0.3 X 103) and 
by HSA (45) at pH 7.4 (nl = 2, 1;: = 1.1 
X lox; n2 = 5, Icz’ = 4.0 X 106; ~2~ = 20, 
1~~’ = 1 X 103) would predicate almost com- 
plete binding of the first few moles of added 
oleate and substantial binding of the rest 
of the added oleate. The binding of salicylate 
by albumin is considerably weaker than that 
of oleate. Davison and Smith (46) have 
reported an association constant of about 2 
X lo4 for the first salicylate binding site on 
BSA at pH 7.4 and weaker binding at five 
other binding sites, and a survey of the 
available data on HSA would suggest that a 
similar situation exists in the human pro- 
tein. Even at low salicylate concentrations 
appreciable amounts of free salicylate will 
be present in the salicylate-containing solu- 
tions. 
Various mechanisms can be considered for 
the alterations in the CD spectra following 
the addition of oleate or snlicylate. It is 
apparent that the spectra do not reflect t’lle 
simple loss of bound bilirubin with no change 
in the manner of binding of the bilirubin 
which remained bound to the albumin. Some 
dislocation or translocation of the bound 
bilirubin or change in the conformation of 
the albumin must have occurred. Since t’he 
lack of information on the conformation of 
albumin in the presence of salicylate and the 
extensive loss of bilirubin at the higher 
oleate concentrations make any interpreta- 
tion of the relevant CD data extremely 
tenuous, we shall restrict, any further discus- 
sion of this topic to the CD spectra which 
were obtained in the presence of low oleate 
concentrations, conditions under which 110 
bilirubin was liberated from the albumin. 
The CD spectral changes which were 
observed under these conditions could result 
from (1) binding of oleate at sites distant 
from the bilirubin binding site with the pro- 
duction of overall conformational changes in 
the albumin, (2) displacement of the bili- 
rubin to secondary binding sites, or (3) 
binding of oleate at, or close to, the bilirubin 
binding site with some perturbation of that 
site. 
(1) Chen (35) has reported that the ORD 
of HSA (0.74 moles fatty acid/mole HSA) at 
pH 7.0 remained unchanged after the pro- 
tein had been defatted (0.01 moles fatty 
acid/mole HSA). Zakrzewski and Goch (47) 
have observed changes in the optical activity 
of HSA at pH 7.0 following the addition of 
up to 10 moles dodecanoate/mole HSA. They 
calculated the MofEt-Tang parameters a,, 
and b. and found that the ORD changes 
were reflected only in the a0 parameter; b. 
remained constant throughout the investi- 
gated range of binding ratios. It would there- 
fore appear that although the addition of 
fatty acid can perturb residues at certain loci 
on the albumin molecule [t’he a,bsorption 
(47) and fluorescence (48) spect,ral changes 
that have been observed after the addition 
of fatty acid offer further evidence of this 
perturbation], the overall structural con- 
formation of the albumin remains unchanged 
after the addition of fatty acid at pH 7.0 
Furthermore, though not absolutely con- 
clusive, the data of Blaucr and Ring (23) 
would suggest that no overall conformational 
changes in the USA occur on the addition of 
bilirubin to BSA at neutral pH values. The 
changes in the CD spectra &ich were ob- 
served on the addition of low oleate con- 
centrations to the 1: 1 bilirubin-albumin 
solutions are thus unlikely to be due to over- 
all conformational changes induced by the 
oleate binding at loci far removed from and 
independent of the bilirubin binding site. 
(2) Since the association constants of the 
primary bilirubin-HSA site (1.3 X lo8 XI-~) 
and the bilirubirlPHSA site (> 107 11-l) are 
much the same or somewhat greater than 
those of the respective primary oleate bind- 
ing sites and since several primary oleate 
binding sites are available for oleate binding, 
one \vould not expect the addition of 1 or 2 
moles of oleate/molc bilirubin-albumin to 
result in any considrrsble displacement of 
the bilirubin from its primary binding site. 
(3) With the information at present 
available, it would appear that, the absorp- 
tion and CD spectral changes could best be 
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explained in terms of oleate-bilirubin- 
albumin int,eraction at tlw bihrubin binding 
site Tvith some result~ant perturbation of the 
sit’e. 
T<ernict’erus, the deposition of UJICOII- 
jugated bilirubin in the central nervous 
system, is a disease of the newborn which 
wpecially threatens premature babies and 
infants with icterus gravis. While a large 
percentage of newborns have serum bilirubin 
Icvels (10 mg/lOO ml or more) higher than 
that8 of the normal adult (1.0 mg/lOO ml), 
most clinicians agree that the critical serum 
limit for the occurrence of kernicterus is 
:ibout 20 mg/lOO ml, and most kcrnicterus 
cases have bilirubin concentrations higher 
t,han this. Most of this excess bilirubin is 
present in the unconjugated form. Studies on 
jaundiced patients have shown that almost 
:dl the bilirubin is bound to albumin (4, 6, 
15) and a serum bilirubin concentration of 
20 mg/lOO ml (0.342 mli) will result in a 
bilirubin: albumin molar ratio of about 0.7. 
High serum free (i.e., nonesterfied) fatty 
acid levels (0.5-2.0 mar) are characteristic of 
newborns (49) and essentially all this fatty 
acid is bound to albumin giving rise to bound 
f:tt,ty acid: albumin molar ratios of between 
1 and 4. The free fatty acid level rises mark 
edly following starvation and any such in- 
crease in the f&y acid level is generally 
paralleled by a decrease in the serum bili- 
rubin level (15, 50). Furthermore, in vitro 
studies OII kernicterus sera and bilirubin- 
albumin solutions (16, 51) have shown that 
t#he addition of oleate will liberate bilirubin 
from the albumin. 
The binding and CD data described in this 
leaper demonstrate that oleate and bilirubin 
compete for the primary bilirubin binding 
site on albumin. While it is hazardous to 
extrapolate in vitro data to the situation iu 
P~UO, the binding data do indicate that any 
increase in the fatty acid:albumin ratio 
above 4 would result in a considerable loss of 
serum bilirubin to the intracellular fluid and 
thus aggravate the disease. The data would 
also suggest that, at high fatty acid levels, 
serum bilirubin values may underestimatfl 
t,he severity of the disease. 
The normal therapeutic serum level of 
salicylate is about 2 mzI resulting in salicg- 
1ate:albumin molar ratios of about 4. The 
studies of S&mid et al. (*X2) on hyperbili- 
rubinemic rats and of Watson (6) 011 human 
subjects have shown a marked decrease in 
the serum bilirubin levels following the in- 
fusion or ingestion of salicylate, and various 
ijl Ldi.0 invest,igatioris (4, 6, 16) have also 
indicated the loss of albumin-bound bilirubin 
in the presence of salicylnte. The binding 
data presented in t’his paper show only a 
slight decrease in the albumin-bound bili- 
rubin 011 the addit’ion of :L 4 M excess of 
salicylate, in marked contrast to the large 
decrease in serum bilirubin observed iu ko. 
The in viuo data cannot be directly explained 
in terms of the i/l rlifw binding data. A 
similar discrepancy has been reported by 
Ode11 et al. (16). These authors observed 
that, at bilirubin:albumin molar ratios less 
than 1, the sera of jnundiccd patients showed 
significant displacement of bilirubin on addi- 
tion of saliq-late whereas comparable bili- 
rub&HSA solutions showed little, if :~l>-, 
displacement of bilirubin from the albumin. 
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